Vermillion Wealth Management, Inc.

Source: SEC Form 13F · as of Mar 2026

Vermillion Wealth Management, Inc. holds 92 biotech & pharma companies tracked by BioSniper, totaling $8.2M in value as of Mar 2026 (SEC Form 13F).

Companies held

92

Total value held

$8.2M

CompanySharesValue
UNHUnitedHealth Group Incorporated Common Stock (DE)13,081$3.5M
LLYELI LILLY & Co3,351$3.1M
JNJJOHNSON & JOHNSON1,194$292K
MRKMerck & Co., Inc.1,499$180K
ABBVAbbVie Inc.816$177K
ABTABBOTT LABORATORIES1,456$149K
AMGNAMGEN INC351$124K
GILDGILEAD SCIENCES, INC.791$110K
PFEPFIZER INC2,352$66K
CORCencora Inc.183$58K
BIIBBIOGEN INC.310$57K
NVSNovartis AG365$56K
BMYBRISTOL MYERS SQUIBB CO751$46K
CAHCardinal Health Inc.213$45K
MCKMcKesson Corporation50$43K
PMPhilip Morris International Inc175$29K
SMMTSummit Therapeutics Inc.1,000$19K
ELVElevance Health Inc.59$17K
TGTXTG THERAPEUTICS, INC.500$17K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)277$15K
GEHCGE HealthCare Technologies Inc.211$15K
IQVIQVIA Holdings Inc.80$14K
TEVATeva Pharmaceutical Industries Limited308$9K
VRTXVERTEX PHARMACEUTICALS INC / MA18$8K
AZNASTRAZENECA PLC34$7K
REGNREGENERON PHARMACEUTICALS, INC.8$6K
AVXLANAVEX LIFE SCIENCES CORP.2,000$6K
GMOptec International, Inc.80$6K
SNYSanofi96$5K
VTRSViatris Inc261$4K
NVONovo Nordisk A/S95$3K
IDXXIDEXX LABORATORIES INC /DE6$3K
INSMINSMED Inc16$3K
CPRXCATALYST PHARMACEUTICALS, INC.100$2K
UTHRUNITED THERAPEUTICS Corp3$2K
ROIVRoivant Sciences Ltd.59$2K
MEDPMedpace Holdings Inc.3$1K
DGXQuest Diagnostics Incorporated7$1K
MRNAModerna, Inc.25$1K
INCYIncyte Corp.13$1K
ZBHZimmer Biomet Holdings Inc.13$1K
BBIOBridgeBio Pharma, Inc.15$1K
TNYATenaya Therapeutics, Inc.1,500$1K
ELANElanco Animal Health Inc43$1K
WSTWest Pharmaceutical Services Inc.4$1K
ALNYALNYLAM PHARMACEUTICALS, INC.3$993
JAZZJazz Pharmaceuticals plc5$945
NBIXNEUROCRINE BIOSCIENCES INC7$922
GHGuardant Health Inc.9$831
TLRYTilray Brands, Inc.128$828
CATXPerspective Therapeutics, Inc.194$809
KRYSKrystal Biotech, Inc.3$775
DVADaVita Inc.5$768
ZTSZoetis Inc.6$709
BMRNBIOMARIN PHARMACEUTICAL INC11$621
GMEDGlobus Medical Inc.7$603
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.3$518
HALOHALOZYME THERAPEUTICS, INC.8$517
NBPNovaBridge Biosciences200$492
PTCTPTC THERAPEUTICS, INC.7$477
CYTKCYTOKINETICS INC7$461
RXRXRECURSION PHARMACEUTICALS, INC.140$430
LGNDLigand Pharmaceuticals Incorporated2$399
ICLRICON plc3$332
RMTIROCKWELL MEDICAL, INC.360$322
TECHBIO-TECHNE Corp6$314
ACADACADIA PHARMACEUTICALS INC14$312
SHCSotera Health Company21$301
PBHPrestige Consumer Healthcare Inc.5$296
RVMDREVOLUTION MEDICINES, INC.3$292
ACBAURORA CANNABIS INC83$271
ICUIICU Medical Inc.2$258
ALKSAlkermes plc.7$248
INDVIndivior Pharmaceuticals, Inc.8$245
CORTCORCEPT THERAPEUTICS INC6$242
LNTHLantheus Holdings, Inc.3$228
IDYAIDEAYA Biosciences, Inc.6$200
RIOTRiot Platforms, Inc.16$198
OGNOrganon & Co.28$166
ADMAADMA BIOLOGICS, INC.12$108
KYMRKymera Therapeutics, Inc.1$83
OSCROscar Health Inc.7$80
CRNXCrinetics Pharmaceuticals, Inc.2$73
MMSIMerit Medical Systems Inc.1$69
RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC.50$40
BAXBaxter International Inc.2$34
CGCCanopy Growth Corp29$28
BEAMBeam Therapeutics Inc.1$24
DNLIDenali Therapeutics Inc.1$19
PGNYProgyny Inc.1$17
PRGOPERRIGO Co plc1$11
RDHLRedHill Biopharma Ltd.2$1

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.